How suspect hysterectomy device got surgeon group's blessing Last May, as controversy mounted over a surgical device called the power morcellator, a professional association for surgeons issued a report defending the tool.
Skin cancer more aggressive with fewer moles present People who have fewer moles may be at higher risk for aggressive melanoma than those with more numerous moles, according to a new study.
What babies eat may affect leukemia risk Infants who start eating solid foods later than usual may be at increased risk for a type of blood cancer, a new study suggests.
Studies still looking for link between cell phones and brain tumors The heaviest users of cell phones may be at higher than average risk of being diagnosed with a brain tumor, according to a recent French study. But for most people, it’s still not clear if there’s added risk, the authors say.
Girl’s nosebleed leads to rare kidney disease diagnosis, parents’ kidney cancer diagnoses A common nosebleed led doctors to diagnose a 14-year-old girl with a rare kidney disease, and, in turn, her mother and father with kidney cancer— the latter of which saved her parents’ lives, CBS 11 reported.
5 things you probably didn't know about breast cancer It’s Breast Cancer Awareness Month. Brush up on your knowledge of the disease here.
Researchers find a link between Jewish women and cancer, without family history Most women only undergo screening for harmful genetic mutations of the BRCA1 and BRCA2 genes if many family members have developed cancer. However, a new study revealed women of Ashkenazi Jewish descent with cancer-causing mutations have a high prevalence of breast cancer and ovarian cancer even if there’s no real family history
New York City man dies weeks after hospice wedding A 26-year-old man with a rare form of cancer has died less than two months after marrying his longtime girlfriend at a New York City hospice.
FDA approves Bristol Myers Squibb’s Opdivo for lung cancer U.S. regulators approved Bristol-Myers Squibb Co. ’s advanced lung cancer drug Opdivo, the latest of a string of events that has focused efforts on using the immune system to battle the disease.
No increase in risky sexual activity with HPV vaccine Vaccinating young girls against the sexually transmitted human papillomavirus (HPV) doesn’t lead to an increase in risky sexual activity, a new study shows.
